Balchem BCPC Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Animal Nutrition and Health | $62.19M+1.7% | $61.17M+8.5% | $56.38M+0.6% | $56.03M-2.2% | $57.28M-1.8% | |
| Human Nutrition and Health | $171.63M+3.3% | $166.07M-4.6% | $174.09M+8.3% | $160.77M+1.5% | $158.46M+7.6% | |
| Specialty Products | $34.73M-0.3% | $34.83M-2.4% | $35.68M-4.0% | $37.19M+11.8% | $33.28M+1.3% | |
| Operating Income (Loss) by Business | ||||||
| Animal Nutrition and Health | $5.69M-8.5% | $6.22M+67.6% | $3.71M+5.7% | $3.51M-32.9% | $5.24M-8.6% | |
| Human Nutrition and Health | $40.02M+8.9% | $36.76M-10.0% | $40.83M+6.5% | $38.34M+1.0% | $37.97M+12.5% | |
| Specialty Products | $11.94M+13.5% | $10.51M-8.9% | $11.53M+2.4% | $11.27M+17.6% | $9.59M-3.8% | |
| Gross Profit by Business | ||||||
| Animal Nutrition and Health | $14.99M+0.5% | $14.91M+27.0% | $11.75M+1.8% | $11.54M-6.6% | $12.36M-6.2% | |
| Human Nutrition and Health | $65.86M+10.2% | $59.78M-6.8% | $64.13M+4.6% | $61.31M+3.8% | $59.07M+6.8% | |
| Specialty Products | $20.46M+4.9% | $19.51M-2.2% | $19.95M-3.2% | $20.61M+19.2% | $17.29M-5.7% | |
| Operating expenses by Business | ||||||
| Animal Nutrition and Health | $9.3M+7.0% | $8.69M+8.2% | $8.03M+0.1% | $8.03M+12.7% | $7.12M-4.4% | |
| Human Nutrition and Health | $25.84M+12.2% | $23.02M-1.2% | $23.3M+1.4% | $22.96M+8.8% | $21.1M-2.1% | |
| Specialty Products | $8.53M-5.3% | $9M+7.0% | $8.41M-10.0% | $9.35M+21.3% | $7.7M-7.9% | |
| Total Assets by Business | ||||||
| Animal Nutrition and Health | $181.04M+2.5% | $176.61M+2.8% | $171.85M-0.8% | $173.19M+2.2% | $169.46M+5.1% | |
| Human Nutrition and Health | $1.25B+0.6% | $1.24B+0.9% | $1.23B-1.1% | $1.25B+2.7% | $1.21B+2.3% | |
| Specialty Products | $169.77M-1.3% | $172.08M-0.2% | $172.5M-1.0% | $174.21M+4.5% | $166.75M+3.4% | |
| Cost of Sales by Business | ||||||
| Animal Nutrition and Health | $47.2M+2.0% | $46.26M+3.7% | $44.63M+0.3% | $44.49M-1.0% | $44.92M-0.5% | |
| Human Nutrition and Health | $105.77M-0.5% | $106.29M-3.3% | $109.96M+10.6% | $99.47M+0.1% | $99.38M+8.0% | |
| Specialty Products | $14.26M-6.9% | $15.32M-2.6% | $15.74M-5.0% | $16.57M+3.7% | $15.99M+10.1% | |
| D&A by Business | ||||||
| Animal Nutrition and Health | $1.86M+0.1% | $1.86M+1.3% | $1.83M+0.3% | $1.83M+3.9% | $1.76M-10.5% | |
| Human Nutrition and Health | $8.65M+12.9% | $7.66M+0.6% | $7.62M+0.9% | $7.54M+3.3% | $7.3M+5.2% | |
| Specialty Products | $1.76M-11.0% | $1.97M+5.3% | $1.87M+4.2% | $1.8M+4.1% | $1.73M-0.2% | |
| CapEx by Business | ||||||
| Animal Nutrition and Health | $2.39M-65.3% | $6.89M+24.9% | $5.52M+165% | $2.08M-11.3% | $2.34M-50.6% | |
| Human Nutrition and Health | $3.16M-55.8% | $7.14M-11.3% | $8.05M+118% | $3.7M+59.0% | $2.33M-59.3% | |
| Specialty Products | $597K-67.9% | $1.86M+71.7% | $1.08M+12.5% | $963K+33.4% | $722K-65.7% | |
| Net Sales by Product | ||||||
| Product Sales Revenue | $270.22M+2.7% | $263.09M-1.5% | $267.08M+4.7% | $255.04M+2.0% | $250.06M+4.4% | |
| Royalty Revenue | $493K-6.1% | $525K+9.4% | $480K+12.7% | $426K-7.0% | $458K+6.3% | |
| Cost of Sales by Product | ||||||
| Raw materials sold | $9.95M+6.6% | $9.34M-0.7% | $9.4M-13.1% | $10.82M+9.0% | $9.93M+16.1% | |
| Services provided | $1.12M-6.4% | $1.19M+7.7% | $1.11M-8.6% | $1.21M+7.5% | $1.13M+2.1% | |
| Net Sales by Geography | ||||||
| Non-US | $73.33M-1.8% | $74.66M+7.4% | $69.49M+1.1% | $68.76M+6.1% | $64.8M+10.8% | |
| United States | $197.38M+4.5% | $188.96M-4.6% | $198.06M+6.1% | $186.71M+0.5% | $185.72M+2.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Balchem break its business down?
- Balchem (BCPC) reports net sales by business across 3 parts — Animal Nutrition and Health, Human Nutrition and Health and Specialty Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Balchem's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Balchem's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
